Preoperative chemotherapy and split-course radiation therapy for patients with localized soft tissue sarcomas: Home run, base hit, or strike out?

Journal of Clinical Oncology

Volumn 24, Issue 4, 2006, Pages 549-551

  Pisters, Peter W T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; MESNA; ANTINEOPLASTIC AGENT; MAID PROTOCOL;

ACUTE GRANULOCYTIC LEUKEMIA; ADJUVANT THERAPY; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL RESEARCH; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; EDITORIAL; HUMAN; META ANALYSIS; PANCREAS ADENOCARCINOMA; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOFT TISSUE SARCOMA; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; ADJUVANT CHEMOTHERAPY; METHODOLOGY; NOTE; SARCOMA; SURVIVAL; TREATMENT FAILURE;

ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DACARBAZINE; DOXORUBICIN; HUMANS; IFOSFAMIDE; MESNA; META-ANALYSIS; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; SARCOMA; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33644841654     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.3026     Document Type: Editorial

References (17)

1. Kraybill WG, Harris JA, Spiro IJ, et al: RTOG 9514: A phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall. J Clin Oncol 24:619-625, 2006
2. Pisters PWT, Patel SR, Varma DGK, et al: Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: Long-term results from a single institution. J Clin Oncol 15:3481-3487, 1997
3. Meric F, Hess K, Varma DG, et al: Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas. Cancer 95:1120-1126, 2002
4. Brennan MF, Singer S, Maki RG, et al: Sarcomas of the soft tissue and bone, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, PA, Lippincott, Williams, and Wilkins, 2004, pp 1581-1637
5. Weitz J, Antonescu CR, Brennan MF: Localized extremity soft tissue sarcoma: Improved knowledge with unchanged survival over time. J Clin Oncol 21:2719-2725, 2003
6. O'Sullivan B, Davis AM, Turcotte R, et al: Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomized trial. Lancet 359:2235-2241, 2002
7. Cormier JN, Huang X, Xing Y, et al: Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: Chemotherapy-associated outcomes. J Clin Oncol 22:4567-4574, 2004
8. Pisters PWT, Harrison LB, Woodruff JM, et al: A prospective randomized trial of adjuvant brachytherapy in the management of low grade soft tissue sarcomas of the extremity and superficial trunk. J Clin Oncol 12:1150-1155, 1994
9. Yang JC, Chang AE, Baker AR, et al: A randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16:197-203, 1998
10. Tierney JF: Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Lancet 350:1647-1654, 1997
11. Brodowicz T, Schwameis E, Widder J, et al: Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: A prospective randomized feasibility trial. Sarcoma 4:151-160, 2000
12. Petrioli R, Coratti A, Correale P, et al: Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma. Am J Clin Oncol 25:468-473, 2002
13. Frustaci S, De Paoli A, Bidoli E, et al: Ifosfamide in the adjuvant therapy of soft tissue sarcomas. Oncology 65:80-84, 2003
14. Frustaci S, Gherlinzoni F, De Paoli A, et al: Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial. J Clin Oncol 19:1238-1247, 2001
15. Bramwell VH: Adjuvant chemotherapy for adult soft tissue sarcoma: Is there a standard of care? J Clin Oncol 19:1235-1237, 2001
16. Grobmyer SR, Maki RG, Demetri GD, et al: Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol 15:1667-1672, 2004
17. Worden FP, Taylor JM, Biermann JS, et al: Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (GCSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma. J Clin Oncol 23:105-112, 2005